Professor Erica Wood is a Transfusion Medicine Specialist, and Head of the Transfusion Research Unit at the School of Public Health and Preventive Medicine at Monash University.  She is co-director of the Division of Acute and Critical Care at SPHPM, and is an NHMRC Leadership Fellow (Level 2, 2020-2024). Erica also works as a Consultant Haematologist at Monash Health and holds an honorary Consultant Haematologist appointment at Peter MacCallum Cancer Centre/Victorian Comprehensive Cancer Centre.

Associate Professor Zoe McQuilten is a haematologist and Deputy Director of the Transfusion Research Unit at the School of Public Health and Preventive Medicine of Monash University. She has a strong interest in supportive care and is the lead investigator of the Immunoglobulin use and outcomes in Chronic lymphocytic leukaemia And Non-Hodgkin lymphoma (ICAN) Study conducted through LaRDR and the RATIONAL platform trial on the use of immunoglobulin replacement therapy in blood cancers.

Neil has over 35 years of blood sector experience, including roles in plasma fractionation at CSL and senior roles in laboratories, manufacturing, quality assurance and transfusion medicine at the Australian Red Cross Blood Service. Neil has managed projects and consulted on regulatory matters for local and international manufacturers of cellular therapeutics. As the International Humanitarian Blood Advisor at Australian Red Cross, Neil has provided advice on blood safety and effectiveness across Asia and the Pacific and managed complex programs across the region.

A/Prof Hawkes provides additional clinical support and expertise to the Lymphoma and Related Diseases Registry. A/Prof Hawkes is an NHMRC fellow and Lymphoma Lead at the Olivia Newton-John Cancer Centre, Austin Health and Eastern Health in Melbourne Australia. She is the founder and past president of the Australasian Lymphoma Alliance, chairs the Australasian Leukaemia and Lymphoma Trials Group Lymphoma Working Party, and is a member of the Steering Committees for Australia and New Zealand Lymphoma Registry and international Women in Lymphoma group. She runs a large research program focusing on immune targets in lymphoma and has over 70 publications.

Naomi oversees and provides strategic support to all registries in the Transfusion Research Unit, Lymphoma and Related Diseases Registry included. She has extensive experience in registries, epidemiology and project management, having previously established the Myeloma and Related Diseases Registry (MRDR) Asia Pacific arm of the MRDR, the Massive Transfusion Registry and the Venous Thromboembolism (VTE) Registry.

Eliza is the project manager of the Lymphoma and Related Diseases Registry. She manages the operational activities, ethics and governance applications, coordinates research projects, and engages with stakeholders of LaRDR. She has increased the number of participating sites by 10 in two years and expanded LaRDR from Australia to New Zealand in 2022. She develops communication materials to inform the different stakeholders of LaRDR's research output. She established the consumer reference group which includes four lymphoma peak bodies to identify gaps and build communication strategies to provide feedback to consumers.

Dr Wellard is experienced in data management of the various registries and trials within the Transfusion Research Unit. Cameron provides technical and statistical expertise in data management, including, but not limited to, data capture, linkage, and analysis. Cameron works closely with project management teams and steering committees to ensure the accuracy and quality of the data for their registries. Cameron has experience across a diverse range of research fields including physics, mathematical biology and cancer epidemiology.

As Data Officer, Dr Chen works on data analysis in malignant haematology and transfusion medicine. Fiona provides support to the Data Manager as well as many registries and clinical trials at Transfusion Research Unit. Fiona graduated from Griffith University on the Gold Coast in January 2021 and moved down to Melbourne soon after.